Showing 35,658 results

Harm reduction

Syringe Programs Boost Hepatitis C Treatment for People Who Inject Drugs

Editor's pick
POZ
16 July 2025
Injectable & long-acting PrEP

Merck to Initiate Phase 3 Trials for Investigational Once-Monthly HIV Prevention Pill

Editor's pick
Merck press release
16 July 2025
HIV & criminal law

New global data reveals rising HIV criminalisation amid stalling legal reforms

Editor's pick
HIV Justice Network
16 July 2025
Injectable & long-acting PrEP

New Analysis Exposes Path to Affordable Lenacapavir for HIV Prevention

Editor's pick
ITPC Global
16 July 2025
Government, leadership & policy

Francois Venter | Slow motion denialism: South Africa's leaders are allowing the HIV response to collapse

Editor's pick
Spotlight
16 July 2025
Travel

Global study reveals 50 countries still enforce HIV-related travel restrictions

Editor's pick
HIV Justice Network
16 July 2025
HIV vaccine & cure research

Engineered T-cells may kill off reservoir cells, mimicking elusive CD8 vaccine effect

News
16 July 2025
Sexually transmitted infections prevention

Resistance is a growing concern amid rising use of doxyPEP

News
16 July 2025

IAS 2025: HIV funding crisis the focus of IAS 2025, 16 July 2025

July 2025
Finance & funding

“We will not go back!”: a powerful, resolute response to funding cuts at IAS 2025

News
16 July 2025
Government, leadership & policy

Rwanda’s HIV leadership on display at IAS 2025

News
16 July 2025
Global health initiatives

Global AIDS funding to be pulled from Trump clawbacks request

Editor's pick
POLITICO
15 July 2025
Injectable & long-acting HIV treatment

ViiV Healthcare and Medicines Patent Pool extend voluntary licensing agreement to enable access to long-acting injectable HIV treatment

Editor's pick
Medicines Patent Pool
15 July 2025
HIV treatment

How treatment works Illustrated

About HIV
July 2025
Access to healthcare

Dutch survey finds informal use of doxyPEP is rising

Editor's pick
CIDRAP
10 July 2025
Pharmaceutical industry

HIV drugmaker Theratechnologies agrees to $254M buyout by CDMO Future Pak

Editor's pick
FiercePharma
10 July 2025
Conference announcements & declarations

IAS 2025 Preview: Amidst a Worldwide Funding Emergency, HIV Science Moves Forward

Editor's pick
TheBodyPro
10 July 2025
PEP

2025 Updates to US HIV nPEP Guidelines: Many Welcome Changes—and One Concern

Editor's pick
TheBodyPro
10 July 2025
Cardiovascular disease

Popular HIV Drug Linked to Higher Risk for MACE

Editor's pick
Medscape (requires free registration)
10 July 2025
Injectable & long-acting PrEP

Global Fund Secures Access to Breakthrough HIV Prevention Drug Lenacapavir for Low- and Middle-Income Countries

Editor's pick
Global Fund News Releases
10 July 2025
Injectable & long-acting PrEP

Gilead to provide HIV prevention drug to 2 million people in lower-income countries at cost

Editor's pick
STAT (requires free registration)
10 July 2025
Cancer

Did Having HIV Increase the Risk of Heywood’s Cancer?

Editor's pick
My Fabulous Disease
10 July 2025
Government, leadership & policy

South Africans fear spike in HIV infections as US aid cuts bite

Editor's pick
BBC News
10 July 2025
Epidemiology

Millions at Risk of HIV Infection and Death After US Funding Cuts, Warns UNAIDS

Editor's pick
Health Policy Watch
10 July 2025